9Fs%kDoñw%*o•$ÑFd go•AoFdoEdaoDaM!oMa
oo☒aoDBB'Fs%kDaoAo§ RMAW.BDBOA.BTBB.EE?ikDaoAwGoo•AoÑdoEd BYAM !fÑoMT%aoDso☒aoTB a%aoTsoaoDBBFs• w£%*•$
B.BE?ikDaoAwGaoTo .rFdoEdaoDaM!MDoTB Bogar
Complete Blood count Electrolytes
O WBC: 4-11 billion cells/L U
Na: 135-145 meq/L
w
HGB: 12-15 g/dl (female) g K: 3.5-5.5 mmol/L
u
HGB: 13.5-17.5 g/dl (male) g
BUN: 7-20 mg/dl (renal labs)
°
PLT: 150-450,000 billion/L ,
Cr: 0.5-1.1 mg/dl (female renal labs)
I
Cr: 0.6- 1.2 mg/dl (male renal labs)
Mg: 1.5-2.5 meq/L
: Ca: 8.5-10.5 mg/dl
Lab values Notes by Morgan Payne
COAGULATION Liver Enzymes
0
PT: 11-13.5 seconds ALT: 7-33 u/L
INR: 0.8-1.2 ratio : AST: 8-48 u/L
: Patients on warfarin: therapeutic range is 2.0-3.0
0
PTT: 30-45 seconds
Vancomycin Serum Gentamicin Serum
Peak: 25-50 mcg/mL Peak: 5-10 mcg/mL
i Trough: 10-20 mcg/mL : Trough: 0.0-2.0 mcg/mL
TTos%kDaoA£%ao•k armored sofar !o7aoMHa%aoTso☒ooD
ardor !o7akMa%aoTso☒ooD BFs%HDoñw%*o•AoÑd so☒ooTBBFs•*oDaoAo§
oEdooDaM!o7aoMHa%aoT oMTÑaooToo☒ooDBBFs
ao•AoÑdoEdooIaG!oFs %kDaoA£%ao•AoÑdoEd ardor !o7aoMHaWooDoo☒ooD
TTFB-okwowwk.org
, •
up me at we up me • as we • up me at we up me • as we •
up me • us we • up • us we • me • at we • me • as me • at we •
up up up we up me as we
Pharmacotherapeutics: study of the beneficial and desired effects and uses of drugs.
B.
:*Pharmacokinetics: study of what the body does to a drug. Es
Mk
B
÷
•
•
Pharmacodynamics: study of a drug’s molecular, biochemical, and physiologic
• BE
.
•
B.
: effects or actions (study of how drugs have effects on the body.
Ed
:
•
B
• •
.
• As
: Pharmacogenetics: studies how a person’s genes affect how he or she responds to
☆
B.
÷ medi
Es
cations. Its long term goal is to help doctors select drugs and doses best suited
Mk
•
•
•
• for each person. BE
☆
.
÷
Ed
•
•
Bk
.
•
•
•
• BE
:
☆
Notes by Morgan Payne
÷ RhaTmacoTagÉrcincireesʰ
B.
Es
'
Pharmacologic principles
•
•
:
•
•
BE
• ☆
÷÷
.
• Es
Mk
.
.
•
BE
:
☆
÷ Generic Name: has components of the chemical name of a drug. A term referring to the
B.
•
BE
.
•
•
•
• Be
•
chemical makeup of a drug rather than to the advertised brand name under which the ☆
.
÷
Es
•
drug is sold (ex: Acetaminophen). Generic drugs are less expensive than brand drugs.
Mk
: .
•
•
NOT ALL DRUGS COME IN GENERIC FORM! BE
÷;
☆
•
GENERIC NAMES DO NOT CHANGE! &
•
•
BE
☆
;֥
Bs
Brand Names: More expensive than generic. Main difference b/t generic Bs
&
.
and brand name drug is the price (ex: Tylenol).
•
•
• BE
.
•
Must know CLASS, GENERIC, and BRAND names as needed. Patients know most drugs
by the brand name.
•
up me • at we • up me • as we • up me • at we • me • us we •
me • at we • me • us me • at we • me • us me • at we •
up up up we up up we up me • at we
,•
up me at we • up w • as we • up me • at we up me as we •
up me • at we • as we me at we • me • us me • at we
up up up up we up me at we
Notes by Morgan Payne
Bs
phao-macae-agicncincirees-B.io
Pharmacologic principles •
Bk
Bk &
Eg Be
•
&
& BE
As
☆
•
HCAI- Health Care Acquired Infection/ Nosocomial Infection: an infection acquired while ☆
•
•
receiving treatment for another condition in a health care facility.
Bs Bk
Bk &
Eg Be
&
Examples:
•
& BE
As ☆
☆ •
Eg
•
Bk
Urine Infections
-
•
&
Bk
Wound Infections
Eg •
Eg
Be
,
& BE
As ☆
Es
☆
•
.
Skin Infections Bs
Es
Ba
Ey
Ba
•
'
Chest Infections G
da
&
Sickness / Diarrhea
& BE
BE ☆
.
☆ •
•
First appear 48 hours or more after hospital admission.
•
5s Bk
Bk &
Eg Be
•
&
& BE
As ☆
☆ •
•
•
Bs
Eg
Bk
Superinfection: infection occurring after or on top of an earlier infection, Bk
&
Be
especially following treatment with broad-spectrum antibiotics. Secondary
•
&
& BE
As ☆
•
infections, c-diff, yeast infection.
☆
•
•
Bk
•
Bk &
Eg Be
•
&
& BE
As ☆
☆ •
Empiric Therapy: based on clinical probabilities and include starting an antibiotic that is
•
•
Bs Bk
Bk &
Eg Be
•
As
•
commonly active against a certain organism. When there is no information you have &
•
☆
☆
Eg
Bk
to make an educated guess before the confirmation of a definitive diagnosis. Bk
&
Be
&
•
As
Examples: Collect culture of wound / blood cultures. &
BE
☆
☆
When a patient comes in with a fever of unknown origin and the results of tests are
•
•
•
Bs Bk
Bk &
Eg
&
•
pending, empiric therapy would be to start this patient on broad spectrum intravenous Be
&
BE
As
☆
antibiotics. ☆
• we •
me • at me • at we • •
?⃝ up
up me as we up up me at we up me • at we up me as we • up me at we • up me • at we Mt at we up me • at we